S3866Temporary National Codes (Non-Medicare)
Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy
Short description: Spec gene test hyp cardiomy
- Effective date
- April 1, 2009
- Termination date
- —
Related codes (S-series)
S0012Butorphanol tartrate, nasalS0013Esketamine, nasal sprayS0014Tacrine hydrochloride, 10 mgS0017Injection, aminocaproic acidS0020Injection, bupivicaine hydroS0021Injection, cefoperazone sodS0023Injection, cimetidine hydrocS0028Injection, famotidine, 20 mgS0030Injection, metronidazoleS0032Injection, nafcillin sodiumS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole
Frequently asked questions
What is HCPCS code S3866?
S3866 is a HCPCS Level II code for Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy.
What category is HCPCS code S3866 in?
S3866 falls under the Temporary National Codes (Non-Medicare) category of HCPCS Level II.
When did HCPCS code S3866 become effective?
S3866 has been effective since April 1, 2009, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.